The clinical practice of palliative sedation in patients dying from COVID-19: a retrospective chart review
Description
CONCLUSION: PS in COVID patients is characterized by rapid clinical deterioration in all phases of the trajectory. What is manifested by earlier dose adjustments and higher hourly doses of midazolam. Timely evaluation of efficacy is recommended in